READ-ONLY DIGITIZATION RESULT
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial.
Gastric Cancer · 2024-Nov · PMID 39162872
Panel A质量警告待 EXE 对齐验证
OS
Fig. 2 a OS. b Forest plot analysis of OS. c Landmark analysis of OS. CAPOX capecitabine plus oxaliplatin, CI confidence interval, ECOG PS Eastern Cooperative Oncology Group performance status, eCRF electronic case report form, HR hazard ratio, IWRS interactive web response system, n/c not countable, OS overall survival, PD-L1 programmed death ligand 1, SOX S-1 (tegafur–gimeracil–oteracil potassium) plus oxaliplatin
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 0.7714 | 75.6098 | 100 | 104 | |
| 1 | 2 | 0.1738 | 0.7714 | 75.6098 | 177 | 104 | |
| 1 | 3 | 0.1896 | 0.7321 | 71.7770 | 184 | 115 | |
| 1 | 4 | 0.1919 | 0.7321 | 71.7770 | 185 | 115 | |
| 1 | 5 | 0.1941 | 0.7321 | 71.7770 | 186 | 115 | |
| 1 | 6 | 0.2144 | 0.6893 | 67.5958 | 195 | 127 | |
| 1 | 7 | 0.3792 | 0.4857 | 47.7352 | 268 | 184 | |
| 1 | 8 | 0.3815 | 0.4786 | 47.0383 | 269 | 186 | |
| 1 | 9 | 0.3837 | 0.4750 | 46.6899 | 270 | 187 | |
| 1 | 10 | 0.3860 | 0.4750 | 46.6899 | 271 | 187 | |
| 1 | 11 | 0.3883 | 0.4750 | 46.6899 | 272 | 187 | |
| 1 | 12 | 0.3905 | 0.4750 | 46.6899 | 273 | 187 | |
| 1 | 13 | 0.3928 | 0.4750 | 46.6899 | 274 | 187 | |
| 1 | 14 | 0.3950 | 0.4750 | 46.6899 | 275 | 187 | |
| 1 | 15 | 0.3973 | 0.4643 | 45.6446 | 276 | 190 | |
| 1 | 16 | 0.3995 | 0.4643 | 45.6446 | 277 | 190 | |
| 1 | 17 | 0.4018 | 0.4607 | 45.2962 | 278 | 191 | |
| 1 | 18 | 0.4041 | 0.4607 | 45.2962 | 279 | 191 | |
| 1 | 19 | 0.4063 | 0.4571 | 44.9477 | 280 | 192 | |
| 1 | 20 | 0.4086 | 0.4571 | 44.9477 | 281 | 192 | |
| 1 | 21 | 0.4108 | 0.4571 | 44.9477 | 282 | 192 | |
| 1 | 22 | 0.4131 | 0.4571 | 44.9477 | 283 | 192 | |
| 1 | 23 | 0.4153 | 0.4393 | 43.2056 | 284 | 197 | |
| 1 | 24 | 0.4176 | 0.4357 | 42.8571 | 285 | 198 | |
| 1 | 25 | 0.4199 | 0.4286 | 42.1603 | 286 | 200 | |
| 1 | 26 | 0.4221 | 0.4286 | 42.1603 | 287 | 200 | |
| 1 | 27 | 0.4244 | 0.4179 | 41.1150 | 288 | 203 | |
| 1 | 28 | 0.4266 | 0.4179 | 41.1150 | 289 | 203 | |
| 1 | 29 | 0.4289 | 0.4143 | 40.7666 | 290 | 204 | |
| 1 | 30 | 0.4312 | 0.4143 | 40.7666 | 291 | 204 | |
| 1 | 31 | 0.4334 | 0.4143 | 40.7666 | 292 | 204 | |
| 1 | 32 | 0.4357 | 0.4143 | 40.7666 | 293 | 204 | |
| 1 | 33 | 0.4379 | 0.4071 | 40.0697 | 294 | 206 | |
| 1 | 34 | 0.4402 | 0.4000 | 39.3728 | 295 | 208 | |
| 1 | 35 | 0.4424 | 0.4000 | 39.3728 | 296 | 208 | |
| 1 | 36 | 0.4447 | 0.4000 | 39.3728 | 297 | 208 | |
| 1 | 37 | 0.4470 | 0.4000 | 39.3728 | 298 | 208 | |
| 1 | 38 | 0.7178 | 0.2571 | 25.4355 | 418 | 248 | |
| 1 | 39 | 0.7314 | 0.2571 | 25.4355 | 424 | 248 | |
| 1 | 40 | 0.9187 | 0.1286 | 12.8920 | 507 | 284 | |
| 1 | 41 | 0.9210 | 0.1286 | 12.8920 | 508 | 284 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 1 | 2026-07-23T18:38:03+00:00 |